{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:24:05Z","timestamp":1784809445703,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Education","award":["FPU21\/05808"],"award-info":[{"award-number":["FPU21\/05808"]}]},{"name":"Ministry of Education","award":["FPU20\/06611"],"award-info":[{"award-number":["FPU20\/06611"]}]},{"name":"Carlos III Health Institute. TransMisiones 2023","award":["PMPTA23\/00025"],"award-info":[{"award-number":["PMPTA23\/00025"]}]},{"name":"Carlos III Health Institute. TransMisiones 2023","award":["PMPTA23\/00025"],"award-info":[{"award-number":["PMPTA23\/00025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-026-00939-6","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:57:14Z","timestamp":1771937834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enhancing prostate cancer diagnosis: a machine learning-based biomarker approach"],"prefix":"10.1186","volume":"20","author":[{"given":"Patricia","family":"Porras-Quesada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ram\u00edrez-Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Arenas-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"V\u00e1zquez-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Alcal\u00e1-Fdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"\u00c1lvarez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Javier","family":"Mart\u00ednez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"\u00c1lvarez-Cubero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"939_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/genes15040450","volume":"15","author":"KCS Silva","year":"2024","unstructured":"Silva KCS, Tambwe N, Mahfouz DH, Wium M, Cacciatore S, Paccez JD, et al. Transcription Factors in Prostate Cancer: Insights for Disease Development and Diagnostic and Therapeutic Approaches. Genes (Basel). 2024;15:450.","journal-title":"Genes (Basel)"},{"key":"939_CR2","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3390\/cancers16071324","volume":"16","author":"M Friedemann","year":"2024","unstructured":"Friedemann M, Jandeck C, Tautz L, Gutewort K, von Rein L, Sukocheva O, et al. Blood-Based DNA Methylation Analysis by Multiplexed OBBPA-ddPCR to Verify Indications for Prostate Biopsies in Suspected Prostate Cancer Patients. Cancers (Basel). 2024;16:1324.","journal-title":"Cancers (Basel)"},{"key":"939_CR3","doi-asserted-by":"crossref","unstructured":"Leung DK, Chiu PK, Ng C, Teoh JY. Role of pre-biopsy multiparametric MRI in prostate cancer diagnosis: Evidence from the literature. Turk J Urol 47 (2020).","DOI":"10.5152\/tud.2020.20360"},{"key":"939_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.euros.2022.08.005","volume":"44","author":"NG Alkema","year":"2022","unstructured":"Alkema NG, Hoogeveen SFJS, Cauberg ECC, Witte LPW, de Kate Mv E, et al. Magnetic Resonance Imaging\u2013targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-na\u00efve Patients with Suspected Prostate Cancer. Eur Urol Open Sci. 2022;44:125\u201330.","journal-title":"Eur Urol Open Sci"},{"key":"939_CR5","first-page":"101097","volume":"26","author":"C Williams","year":"2023","unstructured":"Williams C, Ahdoot M, Daneshvar MA, Hague C, Wilbur AR, Gomella PT, et al. Why Does MRI-Targeted Biopsy Miss Clinically Significant Cancer? J Urol. 2023;26:101097.","journal-title":"J Urol"},{"key":"939_CR6","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/pros.23191","volume":"76","author":"L Van Neste","year":"2016","unstructured":"Van Neste L, Partin AW, Steward GD, Epstein JI, Harrison DJ, Van Criekinge W. Risk score predicts high-grade prostate cancer in DNA\u2010methylation positive, histopathologically negative biopsies. Prostate. 2016;76:1078\u201387.","journal-title":"Prostate"},{"key":"939_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/JU.0000000000000293","volume":"202","author":"A Haese","year":"2019","unstructured":"Haese A, Trooskens G, Steyaert S, Hessels D, Brawer M, Vlaeminck-Guillem V, et al. J Urol. 2019;202:256\u201363.","journal-title":"J Urol"},{"key":"939_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.urology.2024.04.009","volume":"188","author":"SS Ghamande","year":"2024","unstructured":"Ghamande SS, Cline JK, Sayyid RK, Klaassen Z. Advancing Precision Oncology With Artificial Intelligence: Ushering in the ArteraAI Prostate Test. Urology. 2024;188:20\u20133.","journal-title":"Urology"},{"key":"939_CR9","doi-asserted-by":"publisher","first-page":"e28878","DOI":"10.1016\/j.heliyon.2024.e28878","volume":"10","author":"X He","year":"2024","unstructured":"He X, Hu S, Wang C, Yang Y, Li Z, Zeng M, et al. Predicting prostate cancer recurrence: Introducing PCRPS, an advanced online web server. Heliyon. 2024;10:e28878.","journal-title":"Heliyon"},{"key":"939_CR10","doi-asserted-by":"publisher","first-page":"107719","DOI":"10.1016\/j.cmpb.2023.107719","volume":"240","author":"A Ram\u00edrez-Mena","year":"2023","unstructured":"Ram\u00edrez-Mena A, Andr\u00e9s-Le\u00f3n E, Alvarez-Cubero MJ, Anguita-Ruiz A, Martinez-Gonzalez LJ, Alcala-Fdez J. Explainable artificial intelligence to predict and identify prostate cancer tissue by gene expression. Comput Methods Programs Biomed. 2023;240:107719.","journal-title":"Comput Methods Programs Biomed"},{"key":"939_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41586-020-2135-x","volume":"580","author":"J Li","year":"2020","unstructured":"Li J, Xu C, Lee HJ, Ren S, Zi X, Zhang Z, et al. A genomic and epigenomic atlas of prostate cancer in Asian populations. Nature. 2020;580:93\u20139.","journal-title":"Nature"},{"key":"939_CR12","doi-asserted-by":"publisher","first-page":"9172","DOI":"10.1073\/pnas.1100489108","volume":"108","author":"K Kannan","year":"2011","unstructured":"Kannan K, Wang L, Wang J, Ittmann MM, Li W, Yen L. Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing. Proc Natl Acad Sci U S A. 2011;108:9172\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"939_CR13","unstructured":"Lundberg S, Lee S-I. A unified approach to interpreting model predictions. arXiv [cs AI] 4768\u201377, (2017)."},{"key":"939_CR14","doi-asserted-by":"publisher","first-page":"1365615","DOI":"10.3389\/fonc.2024.1365615","volume":"14","author":"T Yang","year":"2024","unstructured":"Yang T, Liu T, Lei T, Li T, Liu N, Zhang M. Unveiling the potential of SLURP1 protein as a biomarker for prostate cancer screening. Front Oncol. 2024;14:1365615.","journal-title":"Front Oncol"},{"key":"939_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.clinbiochem.2023.04.011","volume":"116","author":"Y Mytsyk","year":"2023","unstructured":"Mytsyk Y, Nakonechnyi Y, Dosenko V, Kowal P, Pietrus M, Gazdikova K, et al. The performance and limitations of PCA3, TMPRSS2:ERG, HOXC6 and DLX1 urinary markers combined in the improvement of prostate cancer diagnostics. Clin Biochem. 2023;116:120\u20137.","journal-title":"Clin Biochem"},{"key":"939_CR16","doi-asserted-by":"publisher","first-page":"639164","DOI":"10.3389\/fmolb.2021.639164","volume":"8","author":"G Kong","year":"2021","unstructured":"Kong G, Lee H, Tran Q, Kim C, Park J, Kwon SH, et al. Corrigendum: Current Knowledge on the Function of \u03b1-Methyl Acyl-CoA Racemase in Human Diseases. Front Mol Biosci. 2021;8:639164.","journal-title":"Front Mol Biosci"},{"key":"939_CR17","doi-asserted-by":"publisher","first-page":"e0271981","DOI":"10.1371\/journal.pone.0271981","volume":"17","author":"O Katzendorn","year":"2022","unstructured":"Katzendorn O, von Klot CAJ, Mahjoub S, Faraj Tabrizi P, Harke NN, Tezval H, et al. Combination of PI-RADS score and mRNA urine test-A novel scoring system for improved detection of prostate cancer. PLoS ONE. 2022;17:e0271981.","journal-title":"PLoS ONE"},{"key":"939_CR18","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1038\/s41467-021-25623-2","volume":"12","author":"S Goel","year":"2021","unstructured":"Goel S, Bhatia V, Kundu S, Biswas T, Carskadon S, Gupta N, et al. Transcriptional network involving ERG and AR orchestrates Distal-less homeobox-1 mediated prostate cancer progression. Nat Commun. 2021;12:5325.","journal-title":"Nat Commun"},{"key":"939_CR19","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.3390\/ijms25042222","volume":"25","author":"L Paniagua-Herranz","year":"2024","unstructured":"Paniagua-Herranz L, Moreno I, Nieto-Jim\u00e9nez C, Garcia-Lorenzo E, D\u00edaz-Tejeiro C, Sanvicente A, et al. Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2. Int J Mol Sci. 2024;25:2222.","journal-title":"Int J Mol Sci"},{"key":"939_CR20","doi-asserted-by":"publisher","first-page":"9016","DOI":"10.1038\/s41598-023-36125-0","volume":"13","author":"Y Qian","year":"2023","unstructured":"Qian Y, Feng D, Wang J, Wei W, Wei Q, Han P, et al. Establishment of cancer-associated fibroblasts-related subtypes and prognostic index for prostate cancer through single-cell and bulk RNA transcriptome. Sci Rep. 2023;13:9016.","journal-title":"Sci Rep"},{"key":"939_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/carcin\/bgz129","volume":"41","author":"MF Souza","year":"2020","unstructured":"Souza MF, Kuasne H, Barros-Filho MC, Cili\u00e3o HL, Marchi FA, Fuganti PE, et al. Circulating mRNA signature as a marker for high-risk prostate cancer. Carcinogenesis. 2020;41:139\u201345.","journal-title":"Carcinogenesis"},{"key":"939_CR22","doi-asserted-by":"publisher","first-page":"904315","DOI":"10.3389\/fonc.2022.904315","volume":"12","author":"X Jin","year":"2022","unstructured":"Jin X, Ji J, Niu D, Yang Y, Tao S, Wan L, et al. Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy. Front Oncol. 2022;12:904315.","journal-title":"Front Oncol"},{"key":"939_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MOU.0000000000000384","volume":"27","author":"H Dani","year":"2017","unstructured":"Dani H, Loeb S. The role of prostate cancer biomarkers in undiagnosed men. Curr Opin Urol. 2017;27:210\u20136.","journal-title":"Curr Opin Urol"},{"key":"939_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrurol.2015.159","volume":"12","author":"ML Blute Jr","year":"2015","unstructured":"Blute ML Jr, Abel EJ, Downs TM, Kelcz F, Jarrard DF. Addressing the need for repeat prostate biopsy: new technology and approaches. Nat Rev Urol. 2015;12:435\u201344.","journal-title":"Nat Rev Urol"},{"key":"939_CR25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41391-022-00633-3","volume":"26","author":"JJ Tosoian","year":"2023","unstructured":"Tosoian JJ, Sessine MS, Trock BJ, Ross AE, Xie C, Zheng Y, et al. MyProstateScore in men considering repeat biopsy: validation of a simple testing approach. Prostate Cancer Prostatic Dis. 2023;26:563\u20137.","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-026-00939-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00939-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-026-00939-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:28:33Z","timestamp":1774963713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40246-026-00939-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["939"],"URL":"https:\/\/doi.org\/10.1186\/s40246-026-00939-6","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study participants provided written informed consent before being enrolled, and the study was previously approved by the Research Ethics Committee of Granada Center (CEI-Granada internal code 1638-N-18) following Helsinki ethical declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}